Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03894618
Title	SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Shattuck Labs, Inc.
Indications	lung squamous cell carcinoma lung adenocarcinoma gastric adenocarcinoma anal canal squamous cell carcinoma Advanced Solid Tumor adenosquamous lung carcinoma cervical squamous cell carcinoma renal cell carcinoma melanoma diffuse large B-cell lymphoma Hodgkin's lymphoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma transitional cell carcinoma skin squamous cell carcinoma
Therapies	SL-279252
Age Groups:	adult \| senior
Covered Countries	USA \| ESP \| CAN \| BEL